L
Laura Gribaldo
Researcher at Alternatives
Publications - 110
Citations - 3534
Laura Gribaldo is an academic researcher from Alternatives. The author has contributed to research in topics: Haematopoiesis & Stromal cell. The author has an hindex of 33, co-authored 106 publications receiving 3097 citations. Previous affiliations of Laura Gribaldo include University of Milan & European Commission.
Papers
More filters
Journal ArticleDOI
A modular approach to the ECVAM principles on test validity.
Thomas Hartung,Susanne Bremer,Silvia Casati,S. Coecke,Raffaella Corvi,Salvador Fortaner,Laura Gribaldo,Marlies Halder,Sebastian Hoffmann,Annett Janusch Roi,Pilar Prieto,Enrico Sabbioni,Laurie Scott,Andrew Worth,Valérie Zuang +14 more
TL;DR: Thinking in terms of validity principles will broaden the applicability of the validation process to a variety of tests and procedures, including the generation of new tests, new technologies, computer-based models, and expert systems.
Journal ArticleDOI
Application of the CFU-GM Assay to Predict Acute Drug-Induced Neutropenia: An International Blind Trial to Validate a Prediction Model for the Maximum Tolerated Dose (MTD) of Myelosuppressive Xenobiotics
Augusto Pessina,B. Albella,Maria Bayo,Juan A. Bueren,P Brantom,Silvia Casati,C. Croera,G Gagliardi,P. Foti,Ralph E. Parchment,Dominique Parent-Massin,Greet Schoeters,Y. Sibiril,R. Van Den Heuvel,Laura Gribaldo +14 more
TL;DR: An international blind trial designed to apply a predictive model to calculate the human maximum tolerated dose (MTD) for 20 drugs and confirms that the model can be considered scientifically validated in this study, suggesting promising applications to other areas of research in developing validated hematotoxicological in vitro methods.
Journal ArticleDOI
Prevalidation of a model for predicting acute neutropenia by colony forming unit granulocyte/macrophage (CFU-GM) assay
Augusto Pessina,B. Albella,Juan A. Bueren,P Brantom,Silvia Casati,Laura Gribaldo,C. Croera,G Gagliardi,P. Foti,Ralph E. Parchment,Dominique Parent-Massin,Y. Sibiril,R. Van Den Heuvel +12 more
TL;DR: Results showed that the assay is linear under SOP conditions, and that the in vitro endpoints used by the clinical prediction model of neutropenia are highly reproducible within and between laboratories.
Journal ArticleDOI
Applying 'omics technologies in chemicals risk assessment:: Report of an ECETOC workshop
Roland Buesen,Brian N. Chorley,Beatriz Silva Lima,George P. Daston,Lize Deferme,Timothy M. D. Ebbels,Timothy W. Gant,Amber K. Goetz,John M. Greally,Laura Gribaldo,Jörg Hackermüller,Bruno Hubesch,Danyel Jennen,Kamin J. Johnson,Jun Kanno,Hans-Martin Kauffmann,Madeleine Laffont,Patrick D. McMullen,Richard R. Meehan,Mark Pemberton,Stefania Perdichizzi,Aldert H. Piersma,Ursula G. Sauer,Kerstin Schmidt,Hervé Seitz,Kayo Sumida,Knut Erik Tollefsen,Weida Tong,Tewes Tralau,Ben van Ravenzwaay,Ralf J. M. Weber,Andrew Worth,Carole L. Yauk,Alan Poole +33 more
TL;DR: It was considered promising to strive to link gene expression changes and pathway perturbations to the phenotype by mapping them to specific adverse outcome pathways, and the ECETOC workshop provided important incentives towards achieving this goal.
Journal ArticleDOI
Rotenone exerts developmental neurotoxicity in a human brain spheroid model.
David Pamies,Katharina Block,Pierre Lau,Laura Gribaldo,Carlos A. Pardo,Paula Barreras,Lena Smirnova,Daphne Wiersma,Liang Zhao,Georgina Harris,Thomas Hartung,Helena T. Hogberg +11 more
TL;DR: Results support the idea that rotenone can potentially be a developmental neurotoxicant and show a possible link between previously shown effects on neurite outgrowth and presently observed effects on Ca2+ reabsorption, synaptogenesis and PPAR pathway disruption.